EDIT
Editas Medicine, Inc. Common Stock
stockNASDAQ
At CloseOct 2, 2026 3:59:57 PM EDT
2.62USD+3.770%(+0.10)2,162,809
Pre-marketOct 2, 2026 9:26:30 AM EDT
2.56USD+1.587%(+0.04)
After-hoursOct 2, 2026 4:45:30 PM EDT
2.58USD-1.338%(-0.03)
Loading…
Loading…
401.61M
Healthcare
Biotechnology
HQ
Cambridge, MA, USA
112
Previous Close
$2.52
Beta
2.19
52-Week High
$4.54 2025-10-08
52-Week Low
$1.66 2026-02-05
SMA 50
$2.83
SMA 200
$2.64
Avg. Vol 10D
2.48M
Avg. Vol 30D
2.88M
Avg. Vol 90D
2.77M
Relative Vol
0.75
153.58M
141.95M
92.43%
29,964,193
21.11%
15.72
58%/42%
70.85%
58.79%
0.4100%
800,000
57,754
12,834
57,754
Nov 9, 2026 (35d)
Sep 25, 2026
EU presses UK to align Chinese car tariffs with bloc - report · 
Seeking Alpha
Sep 23, 2026
Gene editing stocks fall after Anthropic’s CRISPR-like discovery · Seeking Alpha
Why is Editas Medicine stock rallying today? · 
Investing.com
Sep 8, 2026
Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer · 
GlobeNewswire Inc.
EDIT Profile
unlocking the promise of genome editing to deliver life-changing medicines. editas medicine's mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.
EDIT Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 2.51 | 2026-09-28 | +4.18% | 2.689 |
| 1M | 3.23 | 2026-09-04 | -19.04% | 3.228 |
| 3M | 3.65 | 2026-07-06 | -28.36% | 1.661 |
| 6M | 2.72 | 2026-04-06 | -3.86% | 1.956 |
| 1Y | 3.92 | 2025-10-03 | -33.29% | 2.189 |
| 2Y | 3.38 | 2024-10-04 | -22.63% | — |
| 5Y | 37.29 | 2021-10-04 | -92.99% | 2.070 |
EDIT Stock Summary
Editas Medicine, Inc. Common Stock (NASDAQ:EDIT) stock price today is $2.62, and today's volume is 2,162,809. EDIT is up 3.770% today. The 30 day average volume is 2.88M. EDIT market cap is $401.61M with 153.58M shares outstanding.